Zacks Investment Research

At the heart of our operations lies a dedicated focus on independent research, aimed at providing valuable insights to investors. Our team is made up of professionals who are genuinely invested in your financial success. Each member is committed to delivering the same trustworthy investment research they would seek for their own portfolios. We have always believed that quantitative models, such as the Zacks Rank, can offer more accurate predictions of stock prices than individual analysts alone. However, we also understand that these models are most effective when used alongside the in-depth knowledge that analysts possess about specific companies and their industries. As a result, Zacks Equity Research merges robust quantitative analysis with the expertise of seasoned equity analysts to offer top-notch long-term stock recommendations.

International, Trade/B2B

English

Research Company/Group

Outlet metrics

Domain Authority

Ranking

Global

#18054

United States

#4328

Finance/Investing

#60

Traffic sources

Monthly visitors

Articles

Pardon Our Interruption

1 month ago | zacks.com
Pardon Our Interruption

2 months ago | zacks.com
Top Analyst Reports for Roche, Comcast & Eaton

2 months ago | zacks.com | Mark Vickery

Monday, March 24, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Roche Holding AG (RHHBY), Comcast Corp. (CMCSA) and Eaton Corp. plc (ETN), as well as a micro-cap stock National Presto Industries, Inc. (NPK). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
Quantum Computing: Tech's Next Giant Leap?

2 months ago | zacks.com | Neena Mishra

(2:00) - Key Takeaways From Nvidia GTC 2025(6:50) - What To Learn From Nvidia’s Quantum Day Events(13:30) - What Investors Need To Know About D-wave Quantum Computing(19:00) - What Exactly Is Quantum Computing And What Are The Recent Developments? (30:30) - What Impact Will Quantum Computing Have On AI? (35:00) - Where Should Investors Look To Gain Exposure To Quantum Computing?
Micron Plunges 8% on Sinking Margins: Time to Sell the Stock?

2 months ago | zacks.com | Anirudha Bhagat

Micron Technology, Inc. ( - Free Report) shares plunged 8% last Friday despite the company reporting better-than-expected second-quarter fiscal 2025 results and offering upbeat guidance for the third quarter. The steep sell-off was driven by growing concerns over its deteriorating gross margin, which overshadowed the otherwise solid revenue and earnings performance. With Friday’s sell-off, MU stock’s year-to-date (YTD) gain has shrunk to 12.6% from 22.4% the day before.
Bull of the Day: Primo Brands Corporation (PRMB)

2 months ago | zacks.com | Ethan Feller

The growing uncertainty and rising volatility in broad markets has me concerned, and I am currently focused on identifying defensive stocks that should hold up well in case there are further declines. Primo Brands Corporation (( - Free Report) ) is a leading consumer staples company, specializing in bottled water, beverage dispensers, and hydration solutions that serve millions across North America.
Bear of the Day: LGI Homes (LGIH)

2 months ago | zacks.com | Ethan Feller

LGI Homes (( - Free Report) ) is a Texas-based homebuilder specializing in entry-level homes across key Sunbelt states, including Texas, Arizona, Florida, and Georgia. These markets thrived during the pandemic-era migration boom, but have since cooled significantly. After a surge in home prices from 2020 to 2022, many of these regions are now seeing price declines and weaker demand. As a result, LGI Homes has experienced slower sales growth and underwhelming stock performance.
ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?

2 months ago | zacks.com | Ekta Bagri

Shares of AC Immune ( - Free Report) have lost 18.3% in the past month compared with the industry’s decline of 1.3%. The stock has underperformed the sector and the S&P 500 Index during this timeframe. Earlier in the month, ACIU reported better-than-expected results for the fourth quarter. Nonetheless, shares of this Switzerland-based clinical-stage biopharmaceutical company continue to slide down.
Wall of Worry: Contrarian Indicators Point to Continued Market Upside

2 months ago | zacks.com | Andrew Rocco

Insider Buys SpikeI often warn investors that insider selling can be a tricky metric to track because company executives will sell stock for a variety of reasons. For instance, many insider sales are pre-planned or are sold due to taxes. In addition, a company executive may sell a stock because they want to retire or purchase a new home – not necessarily because they think their stock will fall. Conversely, insider buying can be among the best signals for individual stocks.
Fed's Stagflation Fears Weigh, Yet Growth Factors Make BSX Stock a Buy

2 months ago | zacks.com | Urmimala Biswas

Boston Scientific ( - Free Report) is experiencing a temporary cooling-off period after its strong run in 2024, where the stock climbed 54.5%, banking on robust financial performance and product advancements throughout the year. The stock's 3% decline so far in March can be attributed to broader market concerns, especially with the Fed's cautious stance on interest rates and economic conditions.